{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:40:31Z","timestamp":1793248831437,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100766"],"award-info":[{"award-number":["32100766"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171416"],"award-info":[{"award-number":["82171416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023B1515020075"],"award-info":[{"award-number":["2023B1515020075"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Fundamental Research Program","doi-asserted-by":"publisher","award":["JCYJ20220530112602006"],"award-info":[{"award-number":["JCYJ20220530112602006"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Fundamental Research Program","doi-asserted-by":"publisher","award":["RCYX20221008092845052"],"award-info":[{"award-number":["RCYX20221008092845052"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Medical Research Fund","award":["A2303039"],"award-info":[{"award-number":["A2303039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06261-4","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T14:57:32Z","timestamp":1741273052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Large-scale CRISPRi screens link metabolic stress to glioblastoma chemoresistance"],"prefix":"10.1186","volume":"23","author":[{"given":"Xing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wansong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7680-6682","authenticated-orcid":false,"given":"Ruilin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"issue":"4","key":"6261_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the Art and future directions. CA Cancer J Clin. 2020;70(4):299\u2013312.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"6261_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.trecan.2022.10.010","volume":"9","author":"MI De Silva","year":"2023","unstructured":"De Silva MI, Stringer BW, Bardy C. Neuronal and tumourigenic boundaries of glioblastoma plasticity. Trends Cancer. 2023;9(3):223\u201336.","journal-title":"Trends Cancer"},{"issue":"12 Suppl 2","key":"6261_CR3","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","volume":"25","author":"QT Ostrom","year":"2023","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2016\u20132020. Neuro Oncol. 2023;25(12 Suppl 2):iv1\u201399.","journal-title":"Neuro Oncol"},{"issue":"2","key":"6261_CR4","doi-asserted-by":"publisher","first-page":"188616","DOI":"10.1016\/j.bbcan.2021.188616","volume":"1876","author":"MS Tomar","year":"2021","unstructured":"Tomar MS, Kumar A, Srivastava C, Shrivastava A. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. Biochim Biophys Acta Rev Cancer. 2021;1876(2):188616.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"5","key":"6261_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant Temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459\u201366.","journal-title":"Lancet Oncol"},{"issue":"10","key":"6261_CR6","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. MGMT gene Silencing and benefit from Temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997\u20131003.","journal-title":"N Engl J Med"},{"key":"6261_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27:441\u201364.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"7","key":"6261_CR8","first-page":"1","volume":"14","author":"KKL Wong","year":"2021","unstructured":"Wong KKL, Verheyen EM. Metabolic reprogramming in cancer: mechanistic insights from Drosophila. Dis Model Mech. 2021;14(7):1\u201317.","journal-title":"Dis Model Mech"},{"issue":"1","key":"6261_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail M, Jiang CH, Li N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol Cancer. 2024;23(1):203.","journal-title":"Mol Cancer"},{"issue":"1","key":"6261_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40164-024-00482-x","volume":"13","author":"J Yang","year":"2024","unstructured":"Yang J, Shay C, Saba NF, Teng Y. Cancer metabolism and carcinogenesis. Exp Hematol Oncol. 2024;13(1):10.","journal-title":"Exp Hematol Oncol"},{"key":"6261_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind JF. Tumor Glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152.","journal-title":"Mol Cancer"},{"issue":"11","key":"6261_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd4145","volume":"12","author":"L Galluzzi","year":"2013","unstructured":"Galluzzi L, Kepp O, Heiden MGV, Kroemer G. Metabolic targets for cancer therapy. Nat Rev Drug Discovery. 2013;12(11):829\u201346.","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"6261_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11033-024-10200-9","volume":"52","author":"L Rajabi","year":"2025","unstructured":"Rajabi L, Ebrahimdoost M, Mohammadi SA, Soleimani Samarkhazan H, Khamisipour G, Aghaei M. Aqueous and ethanolic extracts of Moringa oleifera leaves induce selective cytotoxicity in Raji and Jurkat cell lines by activating the P21 pathway independent of P53. Mol Biol Rep. 2025;52(1):102.","journal-title":"Mol Biol Rep"},{"key":"6261_CR14","doi-asserted-by":"publisher","first-page":"100797","DOI":"10.1016\/j.drup.2021.100797","volume":"59","author":"AC Gon\u00e7alves","year":"2021","unstructured":"Gon\u00e7alves AC, Richiardone E, Jorge J, Pol\u00f3nia B, Xavier CPR, Salaroglio IC, et al. Impact of cancer metabolism on therapy resistance - Clinical implications. Drug Resist Updat. 2021;59:100797.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"6261_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s42255-023-00963-z","volume":"6","author":"M Demicco","year":"2024","unstructured":"Demicco M, Liu X-Z, Leithner K, Fendt S-M. Metabolic heterogeneity in cancer. Nat Metabolism. 2024;6(1):18\u201338.","journal-title":"Nat Metabolism"},{"issue":"12","key":"6261_CR16","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1158\/2159-8290.CD-20-0844","volume":"10","author":"SM Fendt","year":"2020","unstructured":"Fendt SM, Frezza C, Erez A. Targeting metabolic plasticity and flexibility dynamics for Cancer therapy. Cancer Discov. 2020;10(12):1797\u2013807.","journal-title":"Cancer Discov"},{"issue":"1","key":"6261_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5534\/wjmh.230153","volume":"42","author":"CJ Lee","year":"2024","unstructured":"Lee CJ, Yoon H. Metabolic adaptation and cellular stress response as targets for Cancer therapy. World J Mens Health. 2024;42(1):62\u201370.","journal-title":"World J Mens Health"},{"issue":"2","key":"6261_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuron.2019.07.014","volume":"104","author":"R Tian","year":"2019","unstructured":"Tian R, Gachechiladze MA, Ludwig CH, Laurie MT, Hong JY, Nathaniel D, et al. CRISPR Interference-Based platform for multimodal genetic screens in human iPSC-Derived neurons. Neuron. 2019;104(2):239\u2013.\u2013\u200955.e12.","journal-title":"Neuron"},{"issue":"7","key":"6261_CR19","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41593-021-00862-0","volume":"24","author":"R Tian","year":"2021","unstructured":"Tian R, Abarientos A, Hong J, Hashemi SH, Yan R, Dr\u00e4ger N, et al. Genome-wide CRISPRi\/a screens in human neurons link lysosomal failure to ferroptosis. Nat Neurosci. 2021;24(7):1020\u201334.","journal-title":"Nat Neurosci"},{"issue":"1","key":"6261_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41556-021-00821-8","volume":"24","author":"AJ Samelson","year":"2022","unstructured":"Samelson AJ, Tran QD, Robinot R, Carrau L, Rezelj VV, Kain AM, et al. BRD2 Inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2. Nat Cell Biol. 2022;24(1):24\u201334.","journal-title":"Nat Cell Biol"},{"key":"6261_CR21","doi-asserted-by":"crossref","unstructured":"Horlbeck MA, Gilbert LA, Villalta JE, Adamson B, Pak RA, Chen Y et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. Elife. 2016;5.","DOI":"10.7554\/eLife.19760"},{"issue":"1","key":"6261_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13046-024-03027-6","volume":"43","author":"X Li","year":"2024","unstructured":"Li X, Sun S, Zhang W, Liang Z, Fang Y, Sun T, et al. Identification of genetic modifiers enhancing B7-H3-targeting CAR T cell therapy against glioblastoma through large-scale CRISPRi screening. J Exp Clin Cancer Res. 2024;43(1):95.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"6261_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cmet.2020.12.015","volume":"33","author":"D Xu","year":"2021","unstructured":"Xu D, Shao F, Bian X, Meng Y, Liang T, Lu Z. The evolving landscape of noncanonical functions of metabolic enzymes in Cancer and other pathologies. Cell Metab. 2021;33(1):33\u201350.","journal-title":"Cell Metab"},{"issue":"5","key":"6261_CR24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.molcel.2016.02.009","volume":"61","author":"X Li","year":"2016","unstructured":"Li X, Jiang Y, Meisenhelder J, Yang W, Hawke DH, Zheng Y, et al. Mitochondria-Translocated PGK1 functions as a protein kinase to coordinate Glycolysis and the TCA cycle in tumorigenesis. Mol Cell. 2016;61(5):705\u201319.","journal-title":"Mol Cell"},{"issue":"1","key":"6261_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41467-019-13601-8","volume":"11","author":"H Nie","year":"2020","unstructured":"Nie H, Ju H, Fan J, Shi X, Cheng Y, Cang X, et al. O-GlcNAcylation of PGK1 coordinates Glycolysis and TCA cycle to promote tumor growth. Nat Commun. 2020;11(1):36.","journal-title":"Nat Commun"},{"issue":"4","key":"6261_CR26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s10555-024-10206-6","volume":"43","author":"O Ababneh","year":"2024","unstructured":"Ababneh O, Nishizaki D, Kato S, Kurzrock R. Tumor necrosis factor superfamily signaling: life and death in cancer. Cancer Metastasis Rev. 2024;43(4):1137\u201363.","journal-title":"Cancer Metastasis Rev"},{"key":"6261_CR27","doi-asserted-by":"publisher","first-page":"102409","DOI":"10.1016\/j.coi.2023.102409","volume":"86","author":"LF Alim","year":"2024","unstructured":"Alim LF, Keane C, Souza-Fonseca-Guimaraes F. Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment. Curr Opin Immunol. 2024;86:102409.","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"6261_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M. NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309\u201324.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"6261_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6(1):425.","journal-title":"Signal Transduct Target Ther"},{"key":"6261_CR30","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.redox.2017.05.003","volume":"12","author":"AN Shvetsova","year":"2017","unstructured":"Shvetsova AN, Mennerich D, Ker\u00e4t\u00e4r JM, Hiltunen JK, Kietzmann T. Non-electron transfer chain mitochondrial defects differently regulate HIF-1\u03b1 degradation and transcription. Redox Biol. 2017;12:1052\u201361.","journal-title":"Redox Biol"},{"key":"6261_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.redox.2018.08.014","volume":"19","author":"SE Lacher","year":"2018","unstructured":"Lacher SE, Levings DC, Freeman S, Slattery M. Identification of a functional antioxidant response element at the HIF1A locus. Redox Biol. 2018;19:401\u201311.","journal-title":"Redox Biol"},{"issue":"3","key":"6261_CR32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1021\/acsptsci.3c00301","volume":"7","author":"R Akter","year":"2024","unstructured":"Akter R, Awais M, Boopathi V, Ahn JC, Yang DC, Kang SC, et al. Inversion of the Warburg effect: unraveling the metabolic Nexus between obesity and Cancer. ACS Pharmacol Transl Sci. 2024;7(3):560\u201369.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"4","key":"6261_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","volume":"24","author":"GR Steinberg","year":"2023","unstructured":"Steinberg GR, Hardie DG. New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol. 2023;24(4):255\u201372.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"6261_CR34","doi-asserted-by":"publisher","first-page":"113614","DOI":"10.1016\/j.yexcr.2023.113614","volume":"428","author":"A Sharma","year":"2023","unstructured":"Sharma A, Anand SK, Singh N, Dwivedi UN, Kakkar P. AMP-activated protein kinase: an energy sensor and survival mechanism in the reinstatement of metabolic homeostasis. Exp Cell Res. 2023;428(1):113614.","journal-title":"Exp Cell Res"},{"issue":"1","key":"6261_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1158\/2159-8290.CD-17-0712","volume":"8","author":"X Qian","year":"2018","unstructured":"Qian X, Li X, Tan L, Lee JH, Xia Y, Cai Q, et al. Conversion of PRPS hexamer to monomer by AMPK-Mediated phosphorylation inhibits nucleotide synthesis in response to energy stress. Cancer Discov. 2018;8(1):94\u2013107.","journal-title":"Cancer Discov"},{"issue":"24","key":"6261_CR36","doi-asserted-by":"publisher","first-page":"10299","DOI":"10.1158\/0008-5472.CAN-10-1873","volume":"70","author":"SB Rothbart","year":"2010","unstructured":"Rothbart SB, Racanelli AC, Moran RG. Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas. Cancer Res. 2010;70(24):10299\u2013309.","journal-title":"Cancer Res"},{"issue":"4","key":"6261_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.gpb.2020.09.003","volume":"20","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Cong X, Jiang S, Dong Y, Zhao L, Zang Y, et al. Phosphoproteomics reveals the AMPK substrate network in response to DNA damage and histone acetylation. Genomics Proteom Bioinf. 2022;20(4):597\u2013613.","journal-title":"Genomics Proteom Bioinf"},{"issue":"7","key":"6261_CR38","doi-asserted-by":"publisher","first-page":"108713","DOI":"10.1016\/j.celrep.2021.108713","volume":"34","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Dong Y, Luo Y, Jiang S, Meng FL, Tan M, et al. AMPK-mediated phosphorylation on 53BP1 promotes c-NHEJ. Cell Rep. 2021;34(7):108713.","journal-title":"Cell Rep"},{"key":"6261_CR39","doi-asserted-by":"crossref","unstructured":"Jiang J, Ma Y, Yang L, Ma S, Yu Z, Ren X et al. CTR-DB 2.0: an updated cancer clinical transcriptome resource, expanding primary drug resistance and newly adding acquired resistance datasets and enhancing the discovery and validation of predictive biomarkers. Nucleic Acids Res. 2024.","DOI":"10.1093\/nar\/gkae993"},{"issue":"D1","key":"6261_CR40","doi-asserted-by":"publisher","first-page":"D1184","DOI":"10.1093\/nar\/gkab860","volume":"50","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu J, Liu X, Wang X, Xie Q, Zhang X, et al. CTR-DB, an omnibus for patient-derived gene expression signatures correlated with cancer drug response. Nucleic Acids Res. 2022;50(D1):D1184\u201399.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6261_CR41","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1038\/s41467-024-51214-y","volume":"15","author":"M Wu","year":"2024","unstructured":"Wu M, Wang T, Ji N, Lu T, Yuan R, Wu L, et al. Multi-omics and Pharmacological characterization of patient-derived glioma cell lines. Nat Commun. 2024;15(1):6740.","journal-title":"Nat Commun"},{"issue":"1","key":"6261_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12885-022-09211-1","volume":"22","author":"M Sadria","year":"2022","unstructured":"Sadria M, Seo D, Layton AT. The mixed blessing of AMPK signaling in Cancer treatments. BMC Cancer. 2022;22(1):105.","journal-title":"BMC Cancer"},{"issue":"1","key":"6261_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20(1):28.","journal-title":"Mol Cancer"},{"key":"6261_CR44","doi-asserted-by":"crossref","unstructured":"Nong S, Han X, Xiang Y, Qian Y, Wei Y, Zhang T et al. Metabolic reprogramming in cancer: Mechanisms and therapeutics. MedComm (2020). 2023;4(2):e218.","DOI":"10.1002\/mco2.218"},{"issue":"11","key":"6261_CR45","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41556-022-01002-x","volume":"24","author":"KC Kao","year":"2022","unstructured":"Kao KC, Vilbois S, Tsai CH, Ho PC. Metabolic communication in the tumour-immune microenvironment. Nat Cell Biol. 2022;24(11):1574\u201383.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"6261_CR46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.61186\/ijbc.16.2.84","volume":"16","author":"SA Aghapour","year":"2024","unstructured":"Aghapour SA, Torabizadeh M, Bahreiny SS, Saki N, Jalali Far MA, Yousefi-Avarvand A, et al. Investigating the dynamic interplay between cellular immunity and tumor cells in the fight against cancer: an updated comprehensive review. Iran J Blood Cancer. 2024;16(2):84\u2013101.","journal-title":"Iran J Blood Cancer"},{"issue":"1","key":"6261_CR47","doi-asserted-by":"publisher","first-page":"9394","DOI":"10.1038\/s41467-024-53593-8","volume":"15","author":"H Shen","year":"2024","unstructured":"Shen H, Ojo OA, Ding H, Mullen LJ, Xing C, Hossain MI, et al. HIF1\u03b1-regulated Glycolysis promotes activation-induced cell death and IFN-\u03b3 induction in hypoxic T cells. Nat Commun. 2024;15(1):9394.","journal-title":"Nat Commun"},{"key":"6261_CR48","doi-asserted-by":"crossref","unstructured":"Beerkens APM, Heskamp S, Reinema FV, Adema GJ, Span PN, Bussink J. Mitochondria-targeting of oxidative phosphorylation inhibitors to alleviate hypoxia and enhance anticancer treatment efficacy. Clin Cancer Res. 2025.","DOI":"10.1158\/1078-0432.CCR-24-3296"},{"issue":"12","key":"6261_CR49","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"YR Yu","year":"2020","unstructured":"Yu YR, Imrichova H, Wang H, Chao T, Xiao Z, Gao M, et al. Disturbed mitochondrial dynamics in CD8(+) TILs reinforce T cell exhaustion. Nat Immunol. 2020;21(12):1540\u201351.","journal-title":"Nat Immunol"},{"issue":"1","key":"6261_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12943-018-0869-y","volume":"17","author":"C Shao","year":"2018","unstructured":"Shao C, Yang F, Miao S, Liu W, Wang C, Shu Y, et al. Role of hypoxia-induced exosomes in tumor biology. Mol Cancer. 2018;17(1):120.","journal-title":"Mol Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06261-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06261-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06261-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T15:32:14Z","timestamp":1741275134000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06261-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6261"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06261-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"289"}}